Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract
- 27 March 2006
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 78 (18), 2066-2072
- https://doi.org/10.1016/j.lfs.2005.12.004
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small moleculeProceedings of the National Academy of Sciences of the United States of America, 2004
- Amyloid β-Peptide [1-42]-Associated Free Radical-Induced Oxidative Stress And Neurodegeneration in Alzheimers Disease Brain: Mechanisms and ConsequencesCurrent Medicinal Chemistry, 2003
- Effects ofGinkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age-associated cognitive impairmentDrug Development Research, 2002
- Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical ApplicationsCurrent Drug Targets, 2000
- The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloidEuropean Journal of Neuroscience, 2000
- Therapeutic Value of Ginkgo biloba in Reducing Symptoms of Decline in Mental FunctionJournal of Pharmacy and Pharmacology, 1999
- Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.American Journal of Public Health, 1998
- Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor ProteinsNeuron, 1997
- β-Amyloid-Associated Free Radical Oxidative Stress and Neurotoxicity: Implications for Alzheimer's DiseaseChemical Research in Toxicology, 1997
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992